Le Lézard
Classified in: Health
Subject: MRR

Anesthesia laryngeal masks market size to increase by USD 81.18 million: Analysis of major players as well as the key contributor region - Technavio

 North America will account for 40% of the global anesthesia laryngeal masks market

NEW YORK, Jan. 30, 2023 /PRNewswire/ -- North America will account for 40% of the anesthesia laryngeal masks market growth during the forecast period. The increasing prevalence of chronic diseases, increasing adoption of advanced technologies, improved healthcare infrastructure, rising geriatric population, and the presence of prominent vendors are driving the growth of the regional market. The Anesthesia Laryngeal Masks Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to register a growth of USD 81.18 million, however, the growth momentum will decelerate at a CAGR of 6.52% during the forecast period. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download PDF Sample Report

Company profiles

The anesthesia laryngeal masks market report includes information on the key products and recent developments of leading vendors, including:

Market dynamics

The market is driven by factors such as the increasing number of surgeries and emergency cases, the growing prevalence of chronic diseases, and the preference for laryngeal masks over ETTs and bag-valve-mask ventilation. However, the intense competition among vendors leading to price reductions is hindering market growth.

Competitive analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others. Request a Sample

Market segmentation

Related Reports:

Diagnostic Wearable Medical Devices Market by Application, Device, and Geography - Forecast and Analysis 2023-2027: The diagnostic wearable medical devices market is estimated to grow at a CAGR of 15.2% between 2022 and 2027. The size of the market is forecast to increase by USD 7,333.3 million. The growing demand for early diagnosis is notably driving the market growth, although factors such as data privacy issues may impede the market growth. 

Laboratory Shaker Market by Product, Application, and Geography - Forecast and Analysis 2023-2027: The laboratory shaker market is estimated to grow at a CAGR of 7.09% between 2022 and 2027. The size of the market is forecast to increase by USD 611.28 million. The increased use of laboratory shakers in various applications is notably driving the market growth, although factors such as the high cost of laboratory shakers may impede the market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this anesthesia laryngeal mask market report?

Anesthesia Laryngeal Masks Market Scope

Report Coverage


Page number


Base year


Historic period


Forecast period


Growth momentum & CAGR

Decelerate at a CAGR of 6.52%

Market growth 2023-2027

USD 81.18 million

Market structure


YoY growth 2022-2023 (%)


Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 40%

Key countries

US, Germany, UK, Japan, and China

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Ambu AS, Anandic Medical Systems AG, Besmed Health Business Corp., Bunzl Plc, Cardinal Health Inc., Dynarex Corp., Flexicare Group Ltd., HiTech Medical Co. Ltd., HSINER Co. Ltd., ICU Medical Inc., Intersurgical Ltd., Marshall Airway Products Ltd., McKesson Corp., Medtronic Plc, Narang Medical Ltd., Sharn Inc., Sterimed Group, SunMed, Teleflex Inc., and Vogt Medical Vertrieb GmbH

Market dynamics

Parent Market Analysis; Market growth inducers and obstacles; Fast-growing and slow-growing segment analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio "Health Care" Research Reports

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Product

7 Market Segmentation by End-user

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

These press releases may also interest you

at 07:10
The "Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape" report has been added to ResearchAndMarkets.com's offering. This report features an extensive study of some of the key historical and contemporary intellectual property (IP)...

at 07:05
Positive high-level results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed eplontersen met its co-primary endpoints through 66 weeks. The results were consistent...

at 07:05
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing multiple therapeutic platforms intended to enhance Treg function, including biologics and cell therapies, today announced the appointment of Arun...

at 07:05
Neuraly, a clinical-stage biotechnology company pioneering development of disease-modifying agents for neurodegenerative disorders, today announced topline results from the Phase 2 trial with NLY01 in patients with early, untreated Parkinson's...

at 07:05
Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today provided a business update and reported financial results for the year ended December 31, 2022. Net loss for 2022 was $79.4 million, compared to a net...

at 07:05
Seismic Therapeutic, Inc., a biotechnology company using machine learning for immunology drug development, announced today that Melanie Manning has joined the company as Chief People Officer. She is an experienced and versatile human resources (HR)...

News published on 30 january 2023 at 21:00 and distributed by: